Trametinib product-specific bioequivalence guideline
Submitted by Anonymous (not verified) on 19 December 2024 - 12:48
Trametinib product-specific bioequivalence guideline
Human medicines European public assessment report (EPAR): Idelvion, albutrepenonacog alfa, Date of authorisation: 11/05/2016, Revision: 13, Status: Authorised
Submitted by Anonymous (not verified) on 19 December 2024 - 11:27
Human medicines European public assessment report (EPAR): Idelvion, albutrepenonacog alfa, Date of authorisation: 11/05/2016, Revision: 13, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Purevax RCP FeLV, Vaccine against feline viral rhinotracheitis, feline calicivirosis, feline panleucopenia and feline leukaemia, Status: Authorised
Submitted by Anonymous (not verified) on 19 December 2024 - 9:35
Veterinary medicines European public assessment report (EPAR): Purevax RCP FeLV, Vaccine against feline viral rhinotracheitis, feline calicivirosis, feline panleucopenia and feline leukaemia, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Purevax RCP, vaccine against feline viral rhinotracheitis, feline calicivirosis and feline panleucopenia, Status: Authorised
Submitted by Anonymous (not verified) on 19 December 2024 - 9:28
Veterinary medicines European public assessment report (EPAR): Purevax RCP, vaccine against feline viral rhinotracheitis, feline calicivirosis and feline panleucopenia, Status: Authorised
Veterinary medicines European public assessment report (EPAR): Purevax FeLV, vaccine against feline leukaemia, Status: Authorised
Submitted by Anonymous (not verified) on 19 December 2024 - 9:20
Veterinary medicines European public assessment report (EPAR): Purevax FeLV, vaccine against feline leukaemia, Status: Authorised
Article 57 product data
Submitted by Anonymous (not verified) on 19 December 2024 - 9:05
Article 57 product data
Alofisel
Submitted by Anonymous (not verified) on 19 December 2024 - 8:46
Alofisel
Human medicines European public assessment report (EPAR): Zyprexa Velotab, olanzapine, Date of authorisation: 03/02/2000, Revision: 34, Status: Authorised
Submitted by Anonymous (not verified) on 18 December 2024 - 15:47
Human medicines European public assessment report (EPAR): Zyprexa Velotab, olanzapine, Date of authorisation: 03/02/2000, Revision: 34, Status: Authorised
Human medicines European public assessment report (EPAR): Sevelamer carbonate Winthrop (previously Sevelamer carbonate Zentiva), sevelamer carbonate, Date of authorisation: 15/01/2015, Revision: 23, Status: Authorised
Submitted by Anonymous (not verified) on 18 December 2024 - 14:56
Human medicines European public assessment report (EPAR): Sevelamer carbonate Winthrop (previously Sevelamer carbonate Zentiva), sevelamer carbonate, Date of authorisation: 15/01/2015, Revision: 23, Status: Authorised
New fee regulation (from 1 January 2025)
Submitted by Anonymous (not verified) on 18 December 2024 - 14:50
New fee regulation (from 1 January 2025)